Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World

JAMA Intern Med. 2018 Sep 1;178(9):1199-1200. doi: 10.1001/jamainternmed.2018.3025.

Authors

Michael Fralick^{1

2}, Elisabetta Patorno¹, Michael A Fischer¹

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Clinician Scientist Training Program, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 30105365
DOI: 10.1001/jamainternmed.2018.3025

No abstract available

Publication types

Comment

MeSH terms

Amputation, Surgical
Diabetes Mellitus, Type 2*
Glucose
Humans
Lower Extremity
Sodium

Substances

Sodium
Glucose